Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...
AptarGroup, Inc. (NYSE:ATR), a prominent player in drug and consumer product dosing, dispensing, and protection technologies, shared robust third-quarter results marked by solid operational ...
CRYSTAL LAKE, Ill. — CRYSTAL LAKE, Ill. — AptarGroup Inc. (ATR) on Thursday reported third-quarter earnings of $100 million. The Crystal Lake, Illinois-based company said it had net income of ...
Reports Q3 revenue $909.3M, consensus $922.3M. “Aptar delivered another strong quarter driven by our Pharma and Closures segments. We saw increased demand for our proprietary drug delivery ...
For the current quarter ending in December, AptarGroup expects its per-share earnings to range from $1.22 to $1.30. The company expects full-year earnings in the range of $5.34 to $5.42 per share.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
This financial robustness is underpinned by a strong presence in the pharmaceutical segment, which accounts for a significant portion of the group's profits. AptarGroup's ability to maintain and grow ...